ADVOCACY IN ACTION
T
he Pulmonary Hypertension Association (PHA) is the leading voice to Congress and federal agencies on the needs of people with pulmonary hypertension (PH) during the COVID-19 crisis and beyond. Over the past six months, PHA has advocated to: • End surprise medical billing. • Provide robust health insurance coverage for telemedicine and COVID-19 testing and treatment. • Expand paid sick leave benefits. • Enhance access to charitable assistance. PH advocates have been essential to raising congressional awareness and making progress on these issues. This year, PH advocates have sent more than 1,500 email messages to Congress. Others made personal connections in August with legislative staff through phone calls or video conferences. They help educated them about what life with PH is really like and how Congress can help. Become part of PHA’s advocacy network. Visit PHAssociation.org/Advocate or call 301-565-3004 x749.
Holly Szmutko, met virtually this summer with Katherine Hitchcock from the office of Sen. Todd Young (R-Ind.). She is pictured with Rep. Pete Visclosky (D-Ind.) in 2019.
PHA is grateful to our National 2020 PHA O2breathe sponsors for their generous support: Platinum Sponsor Janssen Pharmaceuticals Inc., Gold Sponsor Bayer, and Silver Sponsors CVS Specialty and United Therapeutics.
For up to date information on PHA 2021 Fundraising Events, please visit our website at PHAssociation.org/ pha-fundraising-events/. Contact PHA at Events@PHAssociation.org or 240-485-3810 with questions about PHASSOCIATION.ORG any events.
9
